Sauerbrei A, Wutzler P
Institute of Virology and Antiviral Therapy, Friedrich-Schiller University of Jena, Jena, Germany.
J Med Virol. 2007 Jul;79(7):1025-31. doi: 10.1002/jmv.20879.
The general use of the varicella vaccine requires the surveillance of varicella-zoster virus (VZV) strains in patients infected with VZV. This paper reports the data achieved from a prospective study of genotyping VZV in Germany, analyzing the restriction fragment length polymorphism (RFLP) of the open reading frames (ORF) 38, 54, and 62 as well as the polymorphism of the R5 repeat region. The study included 177 patients with varicella. Seventy-eight patients with zoster served as controls. Results revealed that 78% of VZV strains in patients with varicella had the genetic profile of the dominant wild-genotype occurring in Europe and 22% had the markers of African or Asian strains. Varicella patients with the profile of African or Asian strains were significantly younger than patients with varicella caused by the dominant genotype. By contrast, all zoster patients exhibited strains representing the majority of wild-type strains in Europe. In conclusion, VZV strains from patients with varicella have a significantly higher genetic variability than viral strains from zoster patients. Since variants with the markers of African or Asian strains could only be found in young children with chickenpox, the results suggest a changing scene of VZV genotypes in Germany. As reasons, the spread of viruses, which may be imported originally by persons immigrating from warmer climates, or the recombination between wild-and vaccine-type viruses have to be considered.
水痘疫苗的普遍使用需要对感染水痘带状疱疹病毒(VZV)的患者中的VZV毒株进行监测。本文报告了一项在德国对VZV进行基因分型的前瞻性研究的数据,分析了开放阅读框(ORF)38、54和62的限制性片段长度多态性(RFLP)以及R5重复区域的多态性。该研究纳入了177例水痘患者。78例带状疱疹患者作为对照。结果显示,水痘患者中78%的VZV毒株具有在欧洲出现的优势野生基因型的基因特征,22%具有非洲或亚洲毒株的标记。具有非洲或亚洲毒株特征的水痘患者明显比由优势基因型引起水痘的患者年轻。相比之下,所有带状疱疹患者的毒株均代表欧洲大多数野生型毒株。总之,水痘患者的VZV毒株的基因变异性明显高于带状疱疹患者的病毒毒株。由于仅在患水痘的幼儿中发现具有非洲或亚洲毒株标记的变体,结果提示德国的VZV基因型情况正在发生变化。作为原因,必须考虑最初可能由来自温暖气候地区的移民带入的病毒传播,或野生型与疫苗型病毒之间的重组。